This inventor holds 9 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: National Institute of Health and Medical Research, Centre National De La Recherche Scientifique, Université Paul Sabatier (Toulouse III). Active years: 2003-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Corronsac, FR (2003 - 2018)
- Toulouse, FR (2021)
Company Filing History:
8 out of 1,853 
3 out of 5,383 
2 out of 162 
Years Active: 2003-2021
Title: **Inventor Jean-Jacques Fournie: Advancements in Biomedicine**
Introduction
Jean-Jacques Fournie, located in Corronsac, France, is a prominent inventor recognized for his significant contributions to the field of biomedicine. With an impressive portfolio of nine patents, Fournie's work primarily focuses on innovative solutions for cancer therapy and inflammatory diseases.
Latest Patents
One of Fournie's latest patents, titled "Antibodies targeting tumor associated macrophages and uses thereof," delves into the development of antibodies aimed at Tumor Associated Macrophages (TAMs). This invention investigates specific markers on the surface of macrophages associated with tumors, leading to the determination that sideroflexin 3, a protein absent in normal macrophages, is expressed in TAMs. By creating antibodies directed towards sideroflexin 3, Fournie and his team demonstrated a successful depletion of TAMs in samples from leukemia patients, significantly reducing leukemic B cell numbers.
Another notable patent is "Phosphorylated dendrimers as anti-inflammatory drugs," which features dendrimers with monophosphonic or bisphosphonic terminations aimed at treating inflammatory diseases. This innovative approach could provide new therapeutic avenues for patients suffering from various inflammatory conditions.
Career Highlights
Fournie has made notable strides in his career, particularly in his roles at esteemed research institutions such as the National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale) and the National Centre for Scientific Research (Centre National de la Recherche Scientifique). His work in these institutions has significantly advanced the understanding of immune responses and targeted therapies in biomedicine.
Collaborations
Throughout his career, Jean-Jacques Fournie has collaborated with esteemed colleagues, including Christian Belmant and Marc Bonneville. These partnerships have enriched his research endeavors and contributed to the successful development of his patented technologies.
Conclusion
In summary, Jean-Jacques Fournie stands out as an influential inventor in the field of biomedicine, with his innovative patents reflecting a commitment to advancing treatment options for cancer and inflammatory diseases. His work continues to inspire further research and development, impacting the lives of many patients around the world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile